Answers are grounded in this paper and cite their sources.
Elevated BMI, in the absence of overt metabolic comorbidities, may be associated with accelerated GCIPL atrophy. Obesity, a modifiable risk factor, may be associated with accelerated neurodegeneration in MS.
No takes yet. Share an insight, caveat, or question.
Filippatou et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: